Literature DB >> 11641773

The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells.

C Burek1, J Roth, H G Koch, K Harzer, M Los, K Schulze-Osthoff.   

Abstract

The activation of sphingomyelinases leading to the generation of ceramide has been implicated in various apoptotic pathways. However, the role of ceramide as an essential death mediator remains highly controversial. In the present study, we investigated the functional relevance of ceramide in a genetic model by using primary cells from a Farber disease patient. These cells accumulate ceramide as the result of an inherited deficiency of acidic ceramidase. We demonstrate that Farber disease lymphocytes and fibroblasts underwent apoptosis induced by various stress stimuli, including staurosporine, anticancer drugs and gamma-irradiation, equally as normal control cells. In addition, caspase activation by these proapoptotic agents occurred rather similarly in Farber disease and control fibroblasts. Interestingly, Farber disease lymphoid cells underwent apoptosis induced by the CD95 death receptor more rapidly than control cells. Our data therefore suggest that ceramide does not play an essential role as a second messenger in stress-induced apoptosis. However, in accordance with a role in lipid-rich microdomains, ceramide by altering membrane composition may function as an amplifier in CD95-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641773     DOI: 10.1038/sj.onc.1204841

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Farber's disease without central nervous system involvement: bone-marrow transplantation provides a promising new approach.

Authors:  K Ehlert; J Roth; M Frosch; N Fehse; N Zander; J Vormoor
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

Review 2.  Sphingolipids in the DNA damage response.

Authors:  Brittany Carroll; Jane Catalina Donaldson; Lina Obeid
Journal:  Adv Biol Regul       Date:  2014-11-18

Review 3.  Ceramide: second messenger or modulator of membrane structure and dynamics?

Authors:  Wim J van Blitterswijk; Arnold H van der Luit; Robert Jan Veldman; Marcel Verheij; Jannie Borst
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

4.  Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes.

Authors:  Ruijuan Xu; Wei Sun; Junfei Jin; Lina M Obeid; Cungui Mao
Journal:  FASEB J       Date:  2010-03-05       Impact factor: 5.191

5.  Sphingosine mediates TNFα-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells.

Authors:  Chiara Ullio; Josefina Casas; Ulf T Brunk; Giuseppina Sala; Gemma Fabriàs; Riccardo Ghidoni; Gabriella Bonelli; Francesco M Baccino; Riccardo Autelli
Journal:  J Lipid Res       Date:  2012-03-27       Impact factor: 5.922

Review 6.  Ceramide in apoptosis: a revisited role.

Authors:  Thierry Levade; Sophie Malagarie-Cazenave; Valérie Gouazé; Bruno Ségui; Claudine Tardy; Susan Betito; Nathalie Andrieu-Abadie; Olivier Cuvillier
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 7.  Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.

Authors:  Cungui Mao; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2008-06-13

8.  Farber disease: clinical presentation, pathogenesis and a new approach to treatment.

Authors:  Karoline Ehlert; Michael Frosch; Natalja Fehse; Axel Zander; Johannes Roth; Josef Vormoor
Journal:  Pediatr Rheumatol Online J       Date:  2007-06-29       Impact factor: 3.054

9.  Blockade of lysosomal acid ceramidase induces GluN2B-dependent Tau phosphorylation in rat hippocampal slices.

Authors:  Marie-Elaine Laurier-Laurin; Audrée De Montigny; Suzanne Attiori Essis; Michel Cyr; Guy Massicotte
Journal:  Neural Plast       Date:  2014-09-08       Impact factor: 3.599

10.  Systemic ceramide accumulation leads to severe and varied pathological consequences.

Authors:  Abdulfatah M Alayoubi; James C M Wang; Bryan C Y Au; Stéphane Carpentier; Virginie Garcia; Shaalee Dworski; Samah El-Ghamrasni; Kevin N Kirouac; Mathilde J Exertier; Zi Jian Xiong; Gilbert G Privé; Calogera M Simonaro; Josefina Casas; Gemma Fabrias; Edward H Schuchman; Patricia V Turner; Razqallah Hakem; Thierry Levade; Jeffrey A Medin
Journal:  EMBO Mol Med       Date:  2013-05-16       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.